Msd - Profile
✉ Email this page to a colleague
Drugs and US Patents for Msd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Msd Merck Co | EMEND | aprepitant | FOR SUSPENSION;ORAL | 207865-001 | Dec 17, 2015 | RX | Yes | Yes | 8,258,132 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Msd Sub Merck | SEGLUROMET | ertugliflozin; metformin hydrochloride | TABLET;ORAL | 209806-001 | Dec 19, 2017 | RX | Yes | No | 9,439,902 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Msd Sub Merck | ISENTRESS | raltegravir potassium | TABLET, CHEWABLE;ORAL | 203045-001 | Dec 21, 2011 | RX | Yes | No | 7,169,780*PED | ⤷ Sign Up | ⤷ Sign Up | ||||
| Msd Sub Merck | STEGLATRO | ertugliflozin | TABLET;ORAL | 209803-002 | Dec 19, 2017 | AB | RX | Yes | Yes | 8,080,580 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |
| Msd Sub Merck | BRIDION | sugammadex sodium | SOLUTION;INTRAVENOUS | 022225-001 | Dec 15, 2015 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
| Msd Sub Merck | JANUMET XR | metformin hydrochloride; sitagliptin phosphate | TABLET, EXTENDED RELEASE;ORAL | 202270-001 | Feb 2, 2012 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
